Matthew Eagleton
The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)
This study is a prospective, non-randomized, single-site evaluation of the use of novel endovascular technology to treat complex aortic disease. In an effort to allow for the evaluation of patients with both complex anatomic condition and challenging physiologic situations there are three study subsections as follows: 1. Ascending Arm Protocol: The intended use of the study is to provide endovascular therapy to patients with ascending aortic pathology including aneurysm, pseudoaneurysm, and/or aortic dissection who are considered high risk for conventional surgery. This will involve disease…
Ascending Arm Protocol: 1. General Inclusion Criteria (Must meet ALL of the following): * Life expectancy greater than 2 years * Suitable arterial anatomy * Absence of systemic disease or allergy that precludes an endovascular repair * Capable of giving informed consent and willingness to comply with follow up schedule * Patient is considered high or prohibitive risk for open surgical repair of the ascending aneurysm or dissection 2. Anatomic Inclusion Criteria * Have ONE of the following 1. Focal aneurysm in ascending aorta 2. Pseudoaneurysms and/or dissections…
Endovascular repair of aorta: Patient-specific F/BEVAR treatment
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.